Why This Comparison Matters
Butterfly iQ+ and Philips Lumify sit in the same pocus category but take different approaches. Butterfly iQ+ (Butterfly Network) uses Semiconductor-based ultrasound-on-a-chip (single probe, whole body) while Philips Lumify (Philips Healthcare) uses App-Based Handheld Ultrasound (3 transducer options). Both received FDA clearance (2020 and 2015 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $2,499-$3,999 (probe) + $420/yr (subscription) to $5,995-$9,995 (probe + subscription) price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
The Verdict
Choose Butterfly iQ+ if your practice prioritizes Butterfly Network's ecosystem, brand recognition, or specific clinical advantages. Primary care, urgent care, and emergency physicians who want bedside ultrasound capability without a $50K cart investment. Medical students and residents. The pros that matter most: Lowest entry price for whole-body ultrasound ($2,499); Single probe covers 18 presets (no transducer swapping). The biggest tradeoff to accept: Image quality below cart-based systems for specialized applications.
Choose Philips Lumify if Philips Healthcare's positioning fits better. Cardiology, OB, and specialty practices that want single-application image quality. Buyers that already use Philips imaging and value brand continuity. The pros that matter most: Choice of three dedicated transducers for best image quality per application; PureWave single-crystal transducer design delivers strong image quality. The biggest tradeoff to accept: Highest upfront cost among handheld POCUS options.
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Butterfly iQ+ used units run $1,500-$2,500; Philips Lumify used units run $2,500-$5,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
Frequently Asked Questions
Which is more expensive, Butterfly iQ+ or Philips Lumify?
Butterfly iQ+ runs $2,499-$3,999 (probe) + $420/yr (subscription) new and $1,500-$2,500 used. Philips Lumify runs $5,995-$9,995 (probe + subscription) new and $2,500-$5,000 used. Per-session pricing is N/A for Butterfly iQ+ and N/A for Philips Lumify. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Butterfly iQ+ or Philips Lumify?
Butterfly iQ+ clinical evidence: Growing body of evidence. Multiple studies comparing to cart-based systems across specialties. Philips Lumify clinical evidence: 40+ published studies. Strong cardiac and abdominal imaging comparison data against cart-based systems. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Butterfly iQ+ or Philips Lumify more popular in emergency medicine practices?
Both Butterfly iQ+ and Philips Lumify are commonly used in emergency medicine, internal medicine, family medicine practices. Market share in any given category shifts year to year. Butterfly Network and Philips Healthcare both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Butterfly iQ+ or Philips Lumify?
Both devices are FDA cleared and have established safety profiles. Butterfly iQ+ has these documented concerns: Image quality below cart-based systems for specialized applications. Philips Lumify has: Highest upfront cost among handheld POCUS options. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Butterfly iQ+ and Philips Lumify in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Butterfly iQ+ and Philips Lumify?
Used Butterfly iQ+ sells for $1,500-$2,500 on the secondary market. Used Philips Lumify sells for $2,500-$5,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.